These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes. Kelly C; Swadling L; Brown A; Capone S; Folgori A; Salio M; Klenerman P; Barnes E Eur J Immunol; 2015 Jan; 45(1):309-16. PubMed ID: 25263407 [TBL] [Abstract][Full Text] [Related]
10. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073. Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999 [TBL] [Abstract][Full Text] [Related]
11. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice. Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963 [TBL] [Abstract][Full Text] [Related]
12. Epistatic interactions promote persistence of NS3-Q80K in HCV infection by compensating for protein folding instability. Dultz G; Srikakulam SK; Konetschnik M; Shimakami T; Doncheva NT; Dietz J; Sarrazin C; Biondi RM; Zeuzem S; Tampé R; Kalinina OV; Welsch C J Biol Chem; 2021 Sep; 297(3):101031. PubMed ID: 34339738 [TBL] [Abstract][Full Text] [Related]
13. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection. Guglietta S; Garbuglia AR; Pacciani V; Scottà C; Perrone MP; Laurenti L; Spada E; Mele A; Capobianchi MR; Taliani G; Folgori A; Vitelli A; Ruggeri L; Nicosia A; Piccolella E; Del Porto P Eur J Immunol; 2005 Sep; 35(9):2627-37. PubMed ID: 16114108 [TBL] [Abstract][Full Text] [Related]
14. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Ruhl M; Knuschke T; Schewior K; Glavinic L; Neumann-Haefelin C; Chang DI; Klein M; Heinemann FM; Tenckhoff H; Wiese M; Horn PA; Viazov S; Spengler U; Roggendorf M; Scherbaum N; Nattermann J; Hoffmann D; Timm J; Gastroenterology; 2011 Jun; 140(7):2064-73. PubMed ID: 21376049 [TBL] [Abstract][Full Text] [Related]
15. CD8 epitope escape and reversion in acute HCV infection. Timm J; Lauer GM; Kavanagh DG; Sheridan I; Kim AY; Lucas M; Pillay T; Ouchi K; Reyor LL; Schulze zur Wiesch J; Gandhi RT; Chung RT; Bhardwaj N; Klenerman P; Walker BD; Allen TM J Exp Med; 2004 Dec; 200(12):1593-604. PubMed ID: 15611288 [TBL] [Abstract][Full Text] [Related]
16. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice. Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes. Harcourt GC; Lucas M; Sheridan I; Barnes E; Phillips R; Klenerman P J Viral Hepat; 2004 Jul; 11(4):324-31. PubMed ID: 15230855 [TBL] [Abstract][Full Text] [Related]
18. Conserved hierarchy of helper T cell responses in a chimpanzee during primary and secondary hepatitis C virus infections. Shoukry NH; Sidney J; Sette A; Walker CM J Immunol; 2004 Jan; 172(1):483-92. PubMed ID: 14688358 [TBL] [Abstract][Full Text] [Related]
19. Prediction of T-cell epitopes of hepatitis C virus genotype 5a. Gededzha MP; Mphahlele MJ; Selabe SG Virol J; 2014 Nov; 11():187. PubMed ID: 25380768 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level. Neumann-Haefelin C; Frick DN; Wang JJ; Pybus OG; Salloum S; Narula GS; Eckart A; Biezynski A; Eiermann T; Klenerman P; Viazov S; Roggendorf M; Thimme R; Reiser M; Timm J J Virol; 2008 Apr; 82(7):3438-51. PubMed ID: 18216107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]